Actor
Kenta Biotech Ltd
Focusing on the discovery and development of innovative, fully human monoclonal antibodies for the treatment of life-threatening hospital infections such as hospital acquired pneumonia.
In spite of antibiotic treatment a significant number of patients still die from the infection they acquired at the hospital.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.09 Proteins & Peptides
Business model
1. Entreprise
1.2 Scale-Up
Organization Type
Private Company
Visit website
Domains
Infectious Diseases, Respiratory
Main sector
Biotech
Contact
Rehhagstrasse 79
3018 Bern / BE
031 980 63 38